Brind.
  1. Agilent Technologies opened a biopharma experience centre in Hyderabad as part of its broader India growth strategy.

Agilent Technologies CEO describes market tailwinds and expected acquisition benefits for company growth.

1 report, 1 independent Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Agilent Technologies CEO describes market tailwinds and expected acquisition benefits for company growth.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped